{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:39:56Z","timestamp":1782362396743,"version":"3.54.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/md.0000000000000953","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T18:57:19Z","timestamp":1433962639000},"page":"e953","source":"Crossref","is-referenced-by-count":15,"title":["Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis"],"prefix":"10.1097","volume":"94","author":[{"given":"Zhi-Xian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210309","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives.","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R2-27-20210309","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J Hepatol"},{"key":"R3-27-20210309","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R4-27-20210309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients.","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R5-27-20210309","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"R6-27-20210309","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"R7-27-20210309","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"R8-27-20210309","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLALP autoantibodies in autoimmune hepatitis.","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"R9-27-20210309","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/nar\/gkm1122","article-title":"Structural insights into RNA-dependent eukaryal and archaeal selenocysteine formation.","volume":"36","author":"Araiso","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"R10-27-20210309","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2009.07.005","article-title":"SLALPtRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.","volume":"34","author":"Volkmann","year":"2010","journal-title":"J Autoimmun"},{"key":"R11-27-20210309","first-page":"212","article-title":"Anti-SLA antibody is a marker of severity of liver damage in patients with autoimmune liver disease.","volume":"34","author":"Ma","year":"2001","journal-title":"J Hepatol"},{"key":"R12-27-20210309","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0891693021000054101","article-title":"Frequency and significance of antibodies to soluble liver antigenliver pancreas in variant autoimmune hepatitis.","volume":"35","author":"Czaja","year":"2002","journal-title":"Autoimmunity"},{"key":"R13-27-20210309","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLALP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"R14-27-20210309","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLALP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"R15-27-20210309","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R17-27-20210309","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"R18-27-20210309","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/liv.12022","article-title":"Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.","volume":"33","author":"Efe","year":"2013","journal-title":"Liver Int"},{"key":"R19-27-20210309","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to RoSSA and soluble liver antigen in type 1 autoimmune hepatitis.","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"R20-27-20210309","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigenliver pancreas and HLA risk factors for type 1 autoimmune hepatitis.","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R21-27-20210309","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"R22-27-20210309","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930410001702469","article-title":"Nonstandard antibodies as prognostic markers in autoimmune hepatitis.","volume":"37","author":"Czaja","year":"2004","journal-title":"Autoimmunity"},{"key":"R23-27-20210309","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis.","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"R24-27-20210309","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis.","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"R25-27-20210309","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"R26-27-20210309","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis.","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R27-27-20210309","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","article-title":"Hepatocellular carcinoma in autoimmune hepatitis.","volume":"45","author":"Park","year":"2000","journal-title":"Digest Dis Sci"},{"key":"R28-27-20210309","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2008.08.022","article-title":"Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients.","volume":"50","author":"Werner","year":"2009","journal-title":"J Hepatol"},{"key":"R29-27-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365521.2014.983154","article-title":"Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients.","volume":"50","author":"Danielsson Borssen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R30-27-20210309","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","article-title":"Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.","volume":"101","author":"Sarasin","year":"1996","journal-title":"Am J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:44:58Z","timestamp":1620960298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201506020-00027"}},"subtitle":["A PRISMA-Compliant Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":29,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000953","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}